Pattern of Plasma Lipid Profile among HIV Positive Patients on Anti-Retroviral Therapy
Article Sidebar
:
Main Article Content
Abstract
There are improvements all over the world in the management of HIV/AIDS. However, adverse reactions of drugs used in the treatment are still being observed. Patients on treatment with anti-retroviral drugs are to take these medications for life. Prolonged intake of these drugs needs to be investigated. This study was therefore set up to investigate some associated body derangements involving prolonged anti-retroviral medications such as dyslipidemias. This research was conducted on 260 patients who were HIV positive. Patients who were obese, those on lipid modifying drugs and those who are diabetic or hypertensive were excluded from the study. Parameters of lipid profile except low density lipoprotein – cholesterol were analyzed by the use of commercial kits manufactured by Randox Laboratory, Alden, USA, low density lipoprotein – cholesterol was calculated by the use of Friedewald equation. The plasma HDL-c is significantly higher in female (2.77±1.22) subjects than male (2.36±0.92) subjects (p=0.015). There were no statistically significant differences among the groups considering duration of therapy. Greater percentage of our study population had taken ARD for a period less than 5 years. And there was no significant trend observed in the parameters of lipid profile. The study found no significant association between the parameters of lipid profile and duration of therapy. The greater percentage of our studied population had only taken therapy for less than five years. A regular check on lipid profile may throw more light on this subject.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Souza SJ, Luzia LA., Santos SS, Carvalho RPH. Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review. Rev. da Assoc. Médica Bras. 2013; 59, 186–198.
Ombeni W, Appolinary RK. Lipid Profile in HIV Infected Patients Using First-Line Antiretroviral Drugs. J. Int. Assoc. Provid. AIDS Care. 2016; 15: 164–171.
Indumati V, Vijay V, Shekhanawar MS, Rajeshwari AM., Shantala D. Comparison of serum lipid profile in HIV positive patients on art with art naïve patients. J. Clin. Diagn Res. 2014; 8: CC06–CC09.
Mebrat Y, Amogne W, Mekasha A, Gleason RL, Seifu D. Lipid peroxidation and altered antioxidant profiles with pediatric HIV infection and antiretroviral therapy in Addis Ababa, Ethiopia. J. Trop. Pediatr.2017; 63: 196–202.
Teto G, Kanmogne GD, Torimiro JN, Alemnji G, Nguemaim FN., Takou D, et al. Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon. PLoS One. 2013;8: 1–7.
Zhou DT, Nehumba D, Oktedalen O, Marange P, Kodogo V, Gomo ZA, et al. Changes in lipid profiles of HIV+ adults over nine months at a Harare HIV clinic: A longitudinal study. Biochem. Res. Int.2016;2016.
Suelen JS, Liania AL, Sigrid SS, Carvalho RPH. Lipid profile of HIV-infected patients in relation to antiretroviral therapy: A review. Rev. Assoc. Med. Bras.2013; 59: 186–198.
Oumar AA, Abdoulaye A, Maiga M, Sidibe Y, Cissoko Y, Tulkens P et al. Adverse Drug Reactions to Antiretroviral Therapy (ART): Prospective Study in HIV Infected Adults in Sikasso (Mali). J. Pharmacovigil. 2017; 05.
GomaaS. Adverse effects induced by diclofenac, ibuprofen, and paracetamol toxicity on immunological and biochemical parameters in Swiss albino mice. J. Basic Appl. Zool. 2018; 79: 1–9.
Fowad K, Mohammed A, Mohammed SA, Prem K, Krishna PK. Monitoring of adverse drug reactions associated with antihypertensive medicines at a university teaching hospital in New Delhi. DARU, J. Pharm. Sci. 2012; 20: 1–6.
Mabaso M, Sokhela Z, Mohlabane N, Chibi B, Zuma K. Determinants of HIV infection among adolescent girls and young women aged 15-24 years in South Africa: A 2012 population-based national household survey. BMC Public Health. 2018;18(1):1–7.
Emily F, Philip A. HIV Prevalence and Sexual Behaviour at Older Ages in Rural Malawi. Int J STD AIDS. 2012;23(7):490–6.
13.Roberto WJ, Lima ACS, Pereira DCR, Alencar AMP. Study of lipid profile in a population of university students. Rev. Lat. Am. Enfermagem 2013; 21: 1151–1158.
Michel S. Women and girls, HIV and AIDS. Global information and education on HIV and AIDS. 2019. [internet] https://www.unaids.org/en/keywords/michel-sidib%C3%A9-unaids-executive-director-exd.
15.Tarig AM, Abd Ekarim AA, Mohamed FL. Effects of age and gender on serum lipid profile in over 55 years-old apparently healthy Sudanese individuals. Asian J. Biomed. Pharm. Sci.2013; 3:10–14.
Zhao P, Liu S, Zhong Z, Jing L. Age- and sex-related difference of lipid profile in patients. Medicine (Baltimore). 2018; 97: p e10930.
Kim HJ, Park HA, Cho YG, Kang JH, Kim KW, Kang JH et al. Gender difference in the level of HDL cholesterol in Korean adults. Korean J. Fam. Med. 2011; 32, 173–181.
Shohaimi S, BoekholdtMS, Luben R., Wareham NJ. Distribution of lipid parameters according to different socio-economic indicators- the EPIC-Norfolk prospective population study. BMC Public Health. 2014; 14, 782.
Doddigarla Z, Lingidi JL, Raghib A. Lipid Profile among Art Treated and Untreated Patients in HIV Positive Cases. Arch Med. 2015; 8:2.
Bekolo CE, Nguena MB, Ewane L, Bekoule P, Sylvestre KB. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population. BMC Public Health. 2014; 14, 236.
Fontas E, Leth FV, Sabin CA, Friis-Møller N, Rickenbach M, Monforte A d et al. Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy Are Different Antiretroviral Drugs Associated with Different Lipid Profiles . J. Infect. Dis.2004; 189, 1056–1074.